KCTD17 and metabolic dysfunction-associated steatohepatitis: Our results demonstrate a significant increase in KCTD17 mRNA levels in patients with MASH compared with healthy individuals, with a strong positive correlation between KCTD17 expression and liver fibrosis score across varying degree of MASH severity (Fig. 1d, e).